Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

We have observed 42 EP applications Emma Marie Bassinder has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after September 21, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11791692

4-SUBSTITUTED-3-PHENYLSULFANYLMETHYL-BICYCLO[3.1.0]HEXANE COMPOUNDS AS MGLUR 2/3 ANTAGONISTS

IPC classification:
A61K 31/10, C07C 323/58
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
The patent has been granted
EP11793573

4-SUBSTITUTED-3-BENZYLOXY-BICYCLO[3.1.0]HEXANE COMPOUNDS AS mGluR 2/3 ANTAGONISTS

IPC classification:
A61K 31/21, A61P 25/24, C07C 229/50
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
EXAMINATION IN PROGRESS
EP11813490

BOVINE VIRAL DIARRHEA VIRUS TYPE 1B VACCINE COMPOSITIONS AND METHODS

IPC classification:
A61P 31/14, A61K 39/12
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
EXAMINATION IN PROGRESS
EP12704486

METHODS FOR CONTROLLING PAIN IN CANINES USING A TRANSDERMAL SOLUTION OF FENTANYL

IPC classification:
A61K 9/00, A61K 31/4468
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
EXAMINATION IN PROGRESS
EP12704489

METHODS FOR CONTROLLING PAIN IN EQUINES USING A TRANSDERMAL SOLUTION OF FENTANYL

IPC classification:
A61K 47/14, A61K 47/10, A61K 9/00, A61K 31/4468
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
EXAMINATION IN PROGRESS
EP12726226

SUBSTITUTED INDOLE DERIVATIVES FOR THE TREATMENT OF IMMUNOLOGICAL DISORDERS

IPC classification:
A61K 31/496, C07F 9/141, C07D 401/14, A61P 37/00
Applicant:
Novartis Tiergesundheit AG
Applicant:
Novartis AG
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Agent:
Georg von Sprecher, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12730766

FAST DISSOLVING AZAPERONE GRANULATE FORMULATION

IPC classification:
A61K 31/496, A61K 9/16, A61P 43/00
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
GRANT OF PATENT INTENDED
EP12748299

ANIMAL SUPPLEMENTS AND COMPOSITIONS CONTAINING SOLUBLE MONENSIN AND METHODS THEREFOR

IPC classification:
A23K 1/18, A23K 1/175, A23K 1/17, A23K 1/16
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12707629

ISOXAZOLE DERIVATIVES

IPC classification:
A01N 47/38, A01N 43/80, C07D 419/04, C07D 417/14, C07D 413/14, C07D 413/04
Applicant:
Novartis Tiergesundheit AG
Applicant:
Novartis AG
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Agent:
Bernd Liphardt, Novartis Animal Health Inc
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12721146

PARASITICIDAL DIHYDROISOXAZOLE COMPOUNDS

IPC classification:
A01N 43/80, C07D 495/04, C07D 413/14, C07D 413/04
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13704563

SYSTEM FOR PROVIDING A LIQUID-SUBSTANCE MIXTURE ATTRACTIVE TO AN ANIMAL

IPC classification:
B65D 81/32, B65D 51/28
Applicant:
Novartis Tiergesundheit AG
Applicant:
Novartis AG
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Agent:
Bernd Liphardt, Novartis Animal Health Inc
Status:
PATENT GRANTED
EP13706128

METHODS AND COMPOSITIONS FOR REDUCING THE ENVIRONMENTAL IMPACT OF ANIMAL WASTE

IPC classification:
A23K 1/18, A23K 1/165
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
EXAMINATION IN PROGRESS
EP13721733

TREATMENT OF FISH POPULATIONS WITH LUFENURON

IPC classification:
A61K 31/17, A01N 47/34, A61P 33/14
Applicant:
Novartis Tiergesundheit AG
Applicant:
Novartis AG
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Agent:
Bernd Liphardt, Novartis Animal Health Inc
Status:
PATENT GRANTED
EP13779364

BICYCLIC HETEROARYL CYCLOALKYLDIAMINE DERIVATIVES AS INHIBITORS OF SPLEEN TYROSINE KINASES (SYK)

IPC classification:
A61K 31/5025, C07D 471/04, A61P 37/00, A61P 35/00, A61P 29/00, A61P 11/00
Applicant:
Novartis Tiergesundheit AG
Applicant:
Novartis AG
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Agent:
Georg von Sprecher, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13747376

SUBTITUTED AZINES AS PESTICIDES

IPC classification:
A61K 31/506, A61K 31/505, A01P 17/00, A01N 43/54, C07D 487/10, C07D 413/14, C07D 403/14, C07D 403/12, C07D 403/04, C07D 401/14, C07D 401/12, C07D 401/04, C07D 239/48, C07D 239/47, C07D 213/74
Applicant:
Novartis Tiergesundheit AG
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
PATENT GRANTED
EP12704356

MACROCYCLIC INTEGRASE INHIBITORS FOR USE IN THE TREATMENT OF FELINE IMMUNODEFICIENCY VIRUS

IPC classification:
A61P 31/14, A61K 31/4995, A61K 31/439, C07D 515/18, C07D 498/22, C07D 471/22, C07D 513/18, C07D 471/18
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13799490

NEW TREATMENT

IPC classification:
A01N 51/00
Applicant:
Novartis Tiergesundheit AG
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13785745

AGGRECANASE INHIBITORS

IPC classification:
A61K 31/4166, C07D 233/76
Applicant:
Eli Lilly and Company Limited
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
The patent has been granted
EP13814903

AN ORAL IRON (III) BASED PHOSPHATE ADSORBENT FOR TREATING IRON-DEFICIENCY ANEMIA IN CATS WITH CHRONIC KIDNEY DISEASE

IPC classification:
A61K 33/26, A61P 7/06
Applicant:
Novartis Tiergesundheit AG
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13815504

(HETERO) ARYLACRYLAMIDES FOR THE CONTROL OF ECTOPARASITES

IPC classification:
A01N 43/40, A01N 43/10, A01N 43/08, A01N 43/04, A01N 37/18
Applicant:
Novartis Tiergesundheit AG
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
EXAMINATION IN PROGRESS
EP14712939

1 -HYDROXY-BENZOOXABOROLES AS ANTIPARASITIC AGENTS

IPC classification:
A01N 43/00, C07F 5/02
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
The patent has been granted
EP14733933

PARASITICIDAL COMPOUNDS, METHODS, AND FORMULATIONS

IPC classification:
A61P 33/00, A61K 31/7048, C07H 17/04
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
GRANT OF PATENT INTENDED
EP15193269

NEW COMBINATION

IPC classification:
A61K 47/12, A61K 31/501, A61K 31/4184, A61K 9/20
Applicant:
Novartis Tiergesundheit AG
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
EXAMINATION REQUESTED
EP14840710

METHODS OF USING INTERLEUKIN-10 FOR TREATING DISEASES AND DISORDERS

IPC classification:
A61K 38/20
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11787778

3-SUBSTITUTED-6-(PYRIDINYLMETHOXY)-PYRROLOPYRIDINE COMPOUNDS

IPC classification:
A61P 25/16, A61K 31/437, C07D 471/04
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12704256

ISOXAZOLINE DERIVATIVES FOR CONTROLLING INVERTEBRATE PESTS

IPC classification:
A01N 47/24, A01N 43/84
Applicant:
Novartis AG
Applicant:
Novartis Tiergesundheit AG
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Agent:
Bernd Liphardt, Novartis Animal Health Inc
Status:
GRANT OF PATENT INTENDED
EP14801989

New Compounds

IPC classification:
C07D 211/58, C07D 487/10, C07D 239/42, C07D 401/10, C07D 401/06, C07D 213/74, C07D 401/14
Applicant:
Novartis Tiergesundheit AG
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
EXAMINATION REQUESTED
EP11791146

OXAZOLO[5,4-B]PYRIDIN-5-YL COMPOUNDS AND THEIR USE FOR THE TREATMENT OF CANCER

IPC classification:
A61K 31/424, C07D 498/04, C07D 413/12, A61K 31/437
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP16188388

TREATMENT OF FISH POPULATIONS WITH LUFENURON

IPC classification:
A61K 9/50, A23K 50/80, A23K 20/105, A61P 33/14, A61K 31/17, A01N 47/34
Applicant:
Novartis Tiergesundheit AG
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
Request for examination was made
EP15731204

TRANSDERMAL FORMULATIONS OF PERGOLIDE AND USES THEREOF

IPC classification:
A61K 31/48, A61K 47/40, A61K 9/08, A61K 47/22, A61K 47/20, A61K 47/16, A61K 47/14, A61K 47/10
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
EXAMINATION REQUESTED
EP15760581

NOVEL SULFONYLAMINOBENZAMIDE COMPOUNDS AS ANTHELMINTICS

IPC classification:
A61K 31/18, A61P 33/10, C07C 311/20, C07C 311/08, C07C 205/11, C07D 213/61
Applicant:
Novartis Tiergesundheit AG
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
EXAMINATION REQUESTED
EP15797744

DIARYL ISOXAZOLINE COMPOUND

IPC classification:
A01P 17/00, A01N 43/80, C07D 413/04
Applicant:
Novartis Tiergesundheit AG
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
Request for examination was made
EP15805005

ANTIVIRAL EFFECTS OF NARASIN IN SWINE FEED

IPC classification:
A61P 1/12, A61K 31/351
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
Request for examination was made
EP15801597

1,2-BENZOTHIAZOLE COMPOUNDS FOR THE TREATMENT OF KIDNEY DISORDERS

IPC classification:
A61P 3/10, A61P 13/12, A61K 31/428, C07D 417/06
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
Request for examination was made
EP15874258

METHODS OF IMPROVING YIELD IN RECOMBINANT PROTEIN PRODUCTION

IPC classification:
C07K 1/113, C07K 14/54
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Agent:
Joanna Elizabeth Cripps, Mewburn Ellis LLP
Status:
Request for examination was made
EP16731405

METHODS OF USING INTERLEUKIN-10 FOR TREATING DISEASES AND DISORDERS

IPC classification:
A61P 35/00, G01N 33/50, C07K 14/54, A61K 38/20
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Agent:
Joanna Elizabeth Cripps, Mewburn Ellis LLP
Status:
Request for examination was made
EP16721314

MONENSIN WATER DISPERSIBLE GRANULES BY WET GRANULATION

IPC classification:
A61K 31/351, A61K 9/16, A61K 9/00
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
Request for examination was made
EP16731449

2-OXO-1,3,8-TRIAZASPIRO[4.5]DECAN-3-YL]CARBOXYLIC ACID DERIVATIVES

IPC classification:
A61P 3/10, A61K 31/438, C07D 471/10
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
Request for examination was made
EP16751123

CGRP RECEPTOR ANTAGONISTS

IPC classification:
A61P 25/06, A61K 31/4439, C07D 401/12
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
Request for examination was made
EP16759905

CGRP RECEPTOR ANTAGONISTS

IPC classification:
C07D 487/04, A61K 31/519, A61K 31/4355, C07D 471/04
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
Request for examination was made
EP16840035

METHODS OF USING INTERLEUKIN-10 FOR TREATING DISEASES AND DISORDERS

IPC classification:
A61K 38/20
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Agent:
Joanna Elizabeth Cripps, Mewburn Ellis LLP
Status:
Request for examination was made
EP16785667

GLUCAGON RECEPTOR AGONISTS

IPC classification:
C07K 14/605, A61K 38/26
Applicant:
Eli Lilly and Company Limited
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
Request for examination was made

Please Sign in to use this feature